Abiopharma

NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

New Form 144 - UroGen Pharma Ltd. Filed: 2025-09-09 AccNo: 0001976408-25-000296 Size: 5 KB

Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting

New Form 8-K - Nuwellis, Inc. Filed: 2025-09-09 AccNo: 0001140361-25-034368 Size: 152 KB Item 8.01: Other Events

Capricor Therapeutics Responds to FDA Posting of Complete Response Letter (CRL) for Deramiocel

Smith+Nephew PLC Notification

Silo Pharma Notification (SILO)

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

10x Genomics - CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

New Form 8-K - Microbot Medical Inc. Filed: 2025-09-09 AccNo: 0001641172-25-026942 Size: 13 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting

Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

New Form 8-K - ELUTIA INC. Filed: 2025-09-09 AccNo: 0001104659-25-088481 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference